Patents by Inventor Xiaohui DENG

Xiaohui DENG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12366832
    Abstract: The present application provides a timer, including a base, a driving shaft, and an indicator arm. The driving shaft is rotatably mounted on the base and selectably rotates relative to the base. The indicator arm includes a second support and a plurality of hour blocks. The second support is rotatably connected to the driving shaft. The hour blocks each include a second block body and a second gear. The second block body is rotatably connected to the second support. The second gear is fixedly connected to the second block body. Second protrusion is correspondingly arranged on a rotation path of the second gear around the driving shaft. The second gear has second tooth grooves. The second protrusion selectably extends into the second tooth grooves to drive the second gear to rotate relative to the second support so as to drive the hour blocks to rotate relative to the second support.
    Type: Grant
    Filed: January 15, 2025
    Date of Patent: July 22, 2025
    Assignee: SHENZHEN WEIKE BRAND MANAGEMENT LTD.
    Inventor: Xiaohui Deng
  • Patent number: 12257266
    Abstract: Corneal stromal scars are the leading cause of corneal blindness. The present invention relates to methods and compositions useful in therapies for this pathological condition. The invention provides corneal stromal stem cells and certain other stem cells and as well as exosome polynucleotides produced by such cells, and methods for making and using these cells and compositions. The invention is based upon the discovery that exosomes and their associate active components obtained from these cells comprise agents having the same capacity as corneal stromal stem cells to reduce scarring and prevent scar formation in patients having corneal damage.
    Type: Grant
    Filed: March 4, 2019
    Date of Patent: March 25, 2025
    Assignees: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, UNIVERSITY OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
    Inventors: Sophie Xiaohui Deng, James L. Funderburgh
  • Publication number: 20230210455
    Abstract: The disclosure provides a comprehensive limbal stem cell deficiency diagnostic and staging system that combines observations of physiological parameters such as clinical presentation, central cornea basal cell density, central corneal epithelial thickness, and total corneal nerve fiber length. It has been discovered that the methodology disclosed herein can both accurately and objectively diagnose limbal stem cell deficiency as well as stage its severity.
    Type: Application
    Filed: December 9, 2022
    Publication date: July 6, 2023
    Applicant: The Regents of the University of California
    Inventor: Sophie Xiaohui Deng
  • Publication number: 20210000858
    Abstract: Corneal stromal scars are the leading cause of corneal blindness. The present invention relates to methods and compositions useful in therapies for this pathological condition. The invention provides corneal stromal stem cells and certain other stem cells and as well as exosome polynucleotides produced by such cells, and methods for making and using these cells and compositions. The invention is based upon the discovery that exosomes and their associate active components obtained from these cells comprise agents having the same capacity as corneal stromal stem cells to reduce scarring and prevent scar formation in patients having corneal damage.
    Type: Application
    Filed: March 4, 2019
    Publication date: January 7, 2021
    Applicants: University of Pittsburgh - Of the Commonwealth System of Higher Education, The Regents of the University of California
    Inventors: Sophie Xiaohui Deng, James L. Funderburgh
  • Publication number: 20200123497
    Abstract: A human limbal epithelial stem xenobiotic free cell culture system is provided. The cell culture system typically includes a cell culture media comprising isoproterenol, Human Epidermal Growth Factor (EGF), N2 supplement, hydrocortisone, and an antibiotic. This cell culture media can efficiently propagate undifferentiated LSCs in the absence xenobiotic cells. These systems provide an optimized way to culture LSCs for use in human transplantation (e.g. in patients suffering from limbal stem cell deficiency) by minimizing the risk of cross-contamination and/or reagent toxicity to transplant recipients.
    Type: Application
    Filed: December 12, 2017
    Publication date: April 23, 2020
    Applicant: The Regents of the University of California
    Inventors: Sophie Xiaohui Deng, Sheyla Gonzalez
  • Publication number: 20200056295
    Abstract: The present application refers to a process for preparing of nanostructured metal oxides such as cobalt oxide and transition metal incorporated cobalt oxides and nickel aluminium oxides and nickel metal supported on aluminium oxide using plant material such as spent tea leaves as a hard template and the use of such catalysts for water oxidation.
    Type: Application
    Filed: October 10, 2017
    Publication date: February 20, 2020
    Applicant: STUDIENGESELLSCHAFT KOHLE MBH
    Inventors: Harun TÜYSÜZ, Xiaohui DENG
  • Publication number: 20160376555
    Abstract: The invention disclosed herein provides systems and methods designed to facilitate human limbal stem/progenitor cell culture including a novel 3-dimensional (3D) sandwich method/system in which human limbal stem/progenitor cells and feeder cells are separately cultured on opposite sides of a porous membrane.
    Type: Application
    Filed: June 28, 2016
    Publication date: December 29, 2016
    Inventors: Sophie Xiaohui Deng, Hua Mei, Martin Nakatsu, Sheyla Gonzalez
  • Publication number: 20150175965
    Abstract: The invention disclosed herein provides systems and methods designed to facilitate human limbal stem/progenitor cell culture including a novel 3-dimensional (3D) sandwich method/system in which human limbal stem/progenitor cells and feeder cells are separately cultured on opposite sides of a porous membrane.
    Type: Application
    Filed: December 12, 2013
    Publication date: June 25, 2015
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Sophie Xiaohui Deng, Hua Mei, Martin Nakatsu, Sheyla Gonzalez
  • Patent number: D930072
    Type: Grant
    Filed: December 2, 2020
    Date of Patent: September 7, 2021
    Inventors: Jiedong Zheng, Xiaohui Deng
  • Patent number: D1070970
    Type: Grant
    Filed: December 3, 2024
    Date of Patent: April 15, 2025
    Assignee: Zhuhai Boyeezon Technology co., Ltd
    Inventors: Jiedong Zheng, Xiaohui Deng